PPT-hepatitis Erin Brown Introduction to the patient

about the patient PB 64 yo Caucasian Female Married Daughter Anthropometrics 67 in 170 cm 172 782 kg BMI 269 IBW 135 614 kg IBW 127 Patient history Medical HTN Peripheral neuropathy. Dr. Joanna Eveland, MS, MD. Clinical Chief for Special Populations, MNHC. O. bjectives. Understand recommendations for age cohort and risk based screening for Hepatitis C. Review strategies for health promotion and optimizing treatment readiness for HCV infected homeless individuals. . -Stacey . Trooskin. MD, PhD, Drexel University & . HepCAP. . -Karen Arendt, RN, St. Joseph's Center for Liver & Hepatobiliary Disease. -Courtney Jones, Patient Advocate Foundation. www.nvhr.org/program. Engagement . in . HIV/HCV . Care. Core Competency . 6: . Overcoming Barriers Related to HCV Care. July 2017. Lesson Objectives . Discuss provider knowledge and attitudes regarding HCV treatment of PLWH. Authored and Presented by: LCDR Jonathan Owen, . PharmD. LT Neelam Gazarian, MS, . PharmD. Quentin N. Burdick Memorial Health Care Facility. Indian Health Service. Belcourt, ND. 12/14/2017. Objectives. 1. Nursing . personnel are concerned about acquiring hepatitis B from hepatitis B surface antigen (HBsAg) positive postpartum patients. Which of the following should the ICP recommend?. Screen . personnel annually for HBsAg. in a young girl. Dr.Manoj. . Prakash.J. JR-II. Dept. of Medicine. HISTORY. A 16 Yrs old female patient came to . casulty. . c/o . massive Per vaginal bleeding since 15 days. . She also complained of giddiness and breathlessness on . SOMA SAHA. Assistant Professor & HOD. Department of Food & Nutrition. HMM college for women. WHAT IS HEPATITIS?. Infection and inflammation of liver cell (hepatocyte), resulting in liver cell damage. . PLAN IN . GHANA. ATSU SEAKE-KWAWU, . GHANA HEALTH SERVICE/MOH. MAY 5, 2021. Ghana Background. Population: 30,955,204 (GSS, 2020 . est. ). CBR: 28.826 births per 1000. Expected births (2020): 892,314. National Guidelines for Diagnosis & Management of Viral Hepatitis National Guidelines for PrefaceViral hepatitis is increasingly being recognized as a public health problem in India. While hepatitis A �! & !"#$%&'(#)%"*+"&*,+(-.$%'"&?????????????????????????????????????????????????????????????????????????????????????????????????????????????????012+#)#)3*45*67%8*#%913#:???????????????????????????? PROTOCOL CHECKLIST Enter available information into Merlin upon receipt of initial report Review background on disease, case definition, and laboratory testing Interview patient Incubation period S In Indiana, the 10-year trend of hepatitis A decreased from 329 cases in 1997 to 33 cases in 2006. Many cases have unknown exposures, while some reported traveling internationally. In A in an element INTRODUCTION . DEFINITION . CAUSAL AGENT. EPIDEMIOLOGY . TRANSMISSION . PATHOGENESIS . LIFE CYCLE . CLINICAL FEATURES . LABORATORY DIAGNOSIS . PROPHYLAXIS . TREATMENT . INTRODUCTION . Attempts to identify the group of ‘non- A non-B’ viruses by experimental infection in chimpanzees led to the discovery of hepatitis C virus (HCV). . *Includes case reports indicating the presence of at least one of the following risks 6 weeks to 6 months prior to onset of acute, symptomatic hepatitis C: 1) using injection drugs; 2) having sexual contact with suspected/confirmed hepatitis C patient; 3) being a man who has sex with men; 4) having multiple sex partners concurrently; 5) having household contact with suspected/confirmed hepatitis C patient; 6) having had occupational exposure to blood; 7) being a hemodialysis patient; 8) having received a blood transfusion; 9) having sustained a percutaneous injury; and 10) having undergone surgery..